...
首页> 外文期刊>Ocular oncology and pathology. >A 20-Year Retrospective Review of Retinoblastoma at Two Tertiary Academic Hospitals in Johannesburg, South Africa
【24h】

A 20-Year Retrospective Review of Retinoblastoma at Two Tertiary Academic Hospitals in Johannesburg, South Africa

机译:在南非约翰内斯堡的两位高等教育医院对视网膜母细胞瘤的20年来看

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Aim: This paper presents a 20-year review of retinoblastoma in Johannesburg, South Africa, aiming to better characterize the disease in this sub-Saharan setting. Methods: The study represents a retrospective case series of retinoblastoma patients presenting to Charlotte Maxeke Johannesburg Academic Hospital and Chris Hani Baragwanath Academic Hospital between January 1, 1992, and December 31, 2011. Results: The total number of cases identified was 282, with 245 meeting the study inclusion criteria. Retinoblastoma comprised 6.9% of the total pediatric oncology presentations; 65.3% were unilateral, 34.3% bilateral, and 0.4% trilateral. The overall male-to-female ratio was 1.08. The mean age at presentation overall was 32.6 months (median 28.0), in the unilateral group 39.4 months (median 33.0), and in the bilateral group 19.7 months (median 17.0). The mean delay to presentation overall was 7.0 months (median 4.0). The most frequent presenting symptoms were leukocoria (37.1%) and proptosis (34.7%). The distribution of disease stages at presentation (International Retinoblastoma Staging System) was 1.6% stage 0, 24.1% stage I, 27.8% stage II, 16.3% stage III, and 25.3% stage IV. 26.5% defaulted care. The 5-year Kaplan-Meier survival estimate was 57.7% overall. Conclusion: This study shows that delayed presentation and refusal of therapy remains a significant barrier to effective treatment in this African setting.
机译:目的:本文介绍了南非约翰内斯堡的视网膜母细胞瘤的20年综述,旨在更好地表征该次撒哈拉环境中的疾病。方法:该研究代表了一系列回顾性案例系列的视网膜母细胞瘤患者,其夏洛特Maxeke Johannesburg学术医院和1992年12月1日至2011年12月31日之间。结果:确定的案件总数为282,245符合研究纳入标准。视网膜母细胞瘤包括总儿科肿瘤诊断的6.9%; 65.3%是单侧,34.3%双侧和0.4%三边形。整体映像比例为1.08。演讲中的平均年龄总体年龄为32.6个月(中位数28.0),在单边39.4个月(中位数33.0),双边集团19.7个月(中位数17.0群)。介绍的均值延迟为7.0个月(中位数4.0)。最常见的呈现症状是白细胞(37.1%)和馅目(34.7%)。呈现介绍(国际视网膜母细胞瘤分期系统)的疾病阶段分布为1.6%阶段0,24.1%I阶段I,27.8%II阶段,16.3%III和25.3%阶段IV。 26.5%的违约护理。 5年的Kaplan-Meier生存估计总体增长率为57.7%。结论:本研究表明,延迟呈递和拒绝治疗仍然是在这一非洲环境中有效治疗的重要障碍。

著录项

  • 来源
    《Ocular oncology and pathology.》 |2018年第3期|共6页
  • 作者单位

    Division of Ophthalmology Department of Neurosciences Charlotte Maxeke Johannesburg Academic;

    Division of Ophthalmology Department of Neurosciences Chris Hani Baragwanath Academic Hospital;

    Division of Ophthalmology Department of Neurosciences Charlotte Maxeke Johannesburg Academic;

    Division of Paediatric HaematologyOncology Department of Paediatrics Chris Hani Baragwanath;

    Division of Paediatric HaematologyOncology Department of Paediatrics Charlotte Maxeke;

    Division of Ophthalmology Department of Neurosciences Chris Hani Baragwanath Academic Hospital;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 眼肿瘤;
  • 关键词

    Retinoblastoma; Ocular oncology; South Africa; Mortality;

    机译:视网膜母细胞瘤;眼部肿瘤学;南非;死亡率;

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号